These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38946281)

  • 1. The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment.
    Mattes JA
    Am J Psychiatry; 2024 Jul; 181(7):658. PubMed ID: 38946281
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment: Response to Mattes.
    Najar H; Pålsson E; Landén M
    Am J Psychiatry; 2024 Jul; 181(7):658-659. PubMed ID: 38946272
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine/samidorphan (Lybalvi) for schizophrenia and bipolar disorder.
    Med Lett Drugs Ther; 2021 Nov; 63(1638):191-192. PubMed ID: 35085217
    [No Abstract]   [Full Text] [Related]  

  • 5. Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics.
    Gao K; Kemp DE; Fein E; Wang Z; Fang Y; Ganocy SJ; Calabrese JR
    J Clin Psychiatry; 2011 Aug; 72(8):1063-71. PubMed ID: 21034695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight gain with add-on second-generation antipsychotics in bipolar disorder: a naturalistic study.
    Najar H; Joas E; Kardell M; Pålsson E; Landén M
    Acta Psychiatr Scand; 2017 Jun; 135(6):606-611. PubMed ID: 28407229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A naturalistic retrospective review of weight gain in bipolar patients treated with second generation antipsychotics.
    Worthington MA; El-Mallakh RS
    J Clin Psychopharmacol; 2015 Apr; 35(2):192-3. PubMed ID: 25587693
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
    McClellan JM
    Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
    [No Abstract]   [Full Text] [Related]  

  • 9. Subjective Versus Objective Weight Gain During Acute Treatment With Second-Generation Antipsychotics in Schizophrenia and Bipolar Disorder.
    Gao K; Fang F; Wang Z; Calabrese JR
    J Clin Psychopharmacol; 2016 Dec; 36(6):637-642. PubMed ID: 27753728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and tolerability of atypical antipsychotics in bipolar disorder.
    Seemüller F; Forsthoff A; Dittmann S; Born C; Bernhard B; Severus WE; Grunze H
    Expert Opin Drug Saf; 2005 Sep; 4(5):849-68. PubMed ID: 16111448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain and metabolic issues of medicines used for bipolar disorder.
    Fagiolini A; Chengappa KN
    Curr Psychiatry Rep; 2007 Dec; 9(6):521-8. PubMed ID: 18221634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial weight gain associated with severe carbohydrate craving in a patient receiving quetiapine.
    Kluge M; Dietzel J
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):189-90. PubMed ID: 23581871
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerability profiles of atypical antipsychotics in the treatment of bipolar disorder.
    McIntyre RS; Konarski JZ
    J Clin Psychiatry; 2005; 66 Suppl 3():28-36. PubMed ID: 15762832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of atypical antipsychotics in rapid cycling bipolar disorder: a review of the literature.
    Zupancic ML
    Ann Clin Psychiatry; 2011 May; 23(2):141-9. PubMed ID: 21547275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
    Torrent C; Amann B; Sánchez-Moreno J; Colom F; Reinares M; Comes M; Rosa AR; Scott J; Vieta E
    Acta Psychiatr Scand; 2008 Jul; 118(1):4-18. PubMed ID: 18498432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L; Holt RI; Walker DJ; Hoffmann VP
    Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants and antipsychotics in the long-term treatment of bipolar disorder.
    Kusumakar V
    J Clin Psychiatry; 2002; 63 Suppl 10():23-8. PubMed ID: 12392350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of available agents used to treat bipolar disorder: focus on weight gain.
    Nemeroff CB
    J Clin Psychiatry; 2003 May; 64(5):532-9. PubMed ID: 12755655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial.
    Tramontina S; Zeni CP; Pheula G; Rohde LA
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):129-34. PubMed ID: 17343561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.